Dextromethorphan (DXM) remains one of the most widely utilized antitussive agents in global pharmaceutical markets, with a market value projected to grow from $458.89 million in 2026 to $748.13 million by 2034 at a CAGR of 6.3%. For procurement professionals, understanding the dextromethorphan global buyers list is essential for identifying reliable partners, navigating regulatory complexities, and capitalizing on emerging market opportunities. This guide provides a comprehensive overview of the global dextromethorphan trade landscape, covering top buyers, supplier networks, regulatory developments, and actionable sourcing strategies. Global Dextromethorphan Market Overview The dextromethorphan industry remains a critical segment of the global cough and cold therapeutics market, supported by widespread use of DXM-based formulations…